Annual Debt To Equity
0.10
-0.09-47.37%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual debt to equity ratio is 0.10, with the most recent change of -0.09 (-47.37%) on December 31, 2023.
- During the last 3 years, SABS annual debt to equity has fallen by -0.11 (-52.38%).
- SABS annual debt to equity is now -54.55% below its all-time high of 0.22, reached on December 31, 2021.
Performance
SABS Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.12
0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly debt to equity ratio is 0.12, unchanged on September 30, 2024.
- Over the past year, SABS quarterly debt to equity has dropped by -0.18 (-60.00%).
- SABS quarterly debt to equity is now -60.00% below its all-time high of 0.30, reached on September 30, 2023.
Performance
SABS Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
SABS Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.4% | -60.0% |
| 3 y3 years | -52.4% | -36.8% |
| 5 y5 years | +115.9% | -36.8% |
SABS Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -60.0% | -100.0% |
| 5 y | 5-year | -54.5% | +115.9% | -60.0% | -100.0% |
| alltime | all time | -54.5% | +115.9% | -60.0% | -100.0% |
SAB Biotherapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.12(0.0%) |
| Jun 2024 | - | 0.12(+20.0%) |
| Mar 2024 | - | 0.10(0.0%) |
| Dec 2023 | 0.10(-47.4%) | 0.10(-66.7%) |
| Sep 2023 | - | 0.30(+20.0%) |
| Jun 2023 | - | 0.25(+13.6%) |
| Mar 2023 | - | 0.22(+15.8%) |
| Dec 2022 | 0.19 | 0.19(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 0.19(+18.8%) |
| Jun 2022 | - | 0.16(>+9900.0%) |
| Mar 2022 | - | 0.00(-100.0%) |
| Dec 2021 | 0.22(+4.8%) | 0.22(>+9900.0%) |
| Sep 2021 | - | 0.00(-100.0%) |
| Jun 2021 | - | 0.18(-14.3%) |
| Dec 2020 | 0.21(-133.3%) | 0.21 |
| Dec 2019 | -0.63 | - |
FAQ
- What is SAB Biotherapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual debt to equity year-on-year change?
- What is SAB Biotherapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly debt to equity year-on-year change?
What is SAB Biotherapeutics annual debt to equity ratio?
The current annual debt to equity of SABS is 0.10
What is the all time high annual debt to equity for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual debt to equity ratio is 0.22
What is SAB Biotherapeutics annual debt to equity year-on-year change?
Over the past year, SABS annual debt to equity ratio has changed by -0.09 (-47.37%)
What is SAB Biotherapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of SABS is 0.12
What is the all time high quarterly debt to equity for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly debt to equity ratio is 0.30
What is SAB Biotherapeutics quarterly debt to equity year-on-year change?
Over the past year, SABS quarterly debt to equity ratio has changed by -0.18 (-60.00%)